Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3′-splice site on the HPV-16 genome

Journal of Virology

Volumn 84, Issue 16, 2010, Pages 8219-8230

  Somberg, Monika ^a   Schwartz, Stefan ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN ASF; PROTEIN E4; PROTEIN E6; PROTEIN E7; PROTEIN SF2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; ENHANCER REGION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTO ONCOGENE; RNA SPLICING; VIRUS ATTACHMENT; VIRUS GENOME; VIRUS ONCOGENE;

BASE SEQUENCE; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA SPLICE SITES; RNA SPLICING; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 77954989177     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00462-10     Document Type: Article

References (37)

1. Baker, C., and C. Calef. 1997. Maps of papillomavirus mRNA transcripts. In S. R. Billakanti, C. E. Calef, A. D. Farmer, A. L. Halpern, and G. L. Myers (ed.), Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, NM.
2. Belaguli, N. S., M. M. Pater, and A. Pater. 1992. Nucleotide 880 splice donor site required for efficient transformation and RNA accumulation by human papillomavirus type 16 E7 gene. J. Virol. 66:2724-2730.
3. Caputi, M., M. Freund, S. Kammler, C. Asang, and H. Schaal. 2004. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J. Virol. 78:6517-6526.
4. Cartegni, L., J. Wang, Z. Zhu, M. Q. Zhang, and A. R. Krainer. 2003. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31:3568-3571.
5. Chow, L. T., M. Nasseri, S. M. Wolinsky, and T. R. Broker. 1987. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 61:2581-2588.
6. Doorbar, J., A. Parton, K. Hartley, L. Banks, T. Crook, M. Stanley, and L. Crawford. 1990. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 178:254-262.
7. Fay, J., P. Kelehan, H. Lambkin, and S. Schwartz. 2009. Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer. J. Med. Virol. 81:897-907.
8. Graham, S. V. 2008. Papillomavirus 3′ UTR regulatory elements. Front. Biosci. 13:5646-5663.
9. Grassmann, K., B. Rapp, H. Maschek, K. U. Petry, and T. Iftner. 1996. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70:2339-2349.
10. Howley, P. M., and D. R. Lowy. 2001. Papillomaviridae and their replication, p. 2197-2229. In Knipe, D. M., P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Hummel, M., J. B. Hudson, and L. A. Laimins. 1992. Differentiation- induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:6070-6080.
12. Hummel, M., H. B. Lim, and L. A. Laimins. 1995. Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J. Virol. 69:3381-3388.
13. Johansson, C., H. Zhao, E. Bajak, F. Granberg, U. Pettersson, and C. Svensson. 2005. Impact of the interaction between adenovirus E1A and CtBP on host cell gene expression. Virus Res. 113:51-63.
14. Karni, R., E. de Stanchina, S. W. Lowe, R. Sinha, D. Mu, and A. R. Krainer. 2007. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 14:185-193.
15. Klumpp, D., F. Stubenrauch, and L. A. Laimins. 1997. Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus 31 on stable and transient viral replication. J. Virol. 71:8186-8194.
16. Longworth, M. S., and L. A. Laimins. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362-372.
17. Milligan, S. G., T. Veerapraditsin, B. Ahamet, S. Mole, and S. V. Graham. 2007. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360:172-181.
18. Mole, S., M. McFarlane, T. Chuen-Im, S. G. Milligan, D. Millan, and S. V. Graham. 2009. RNA splicing factors regulated by HPV16 during cervical tumour progression. J. Pathol. 219:383-391.
19. Mole, S., S. G. Milligan, and S. V. Graham. 2009. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J. Virol. 83:357-367.
20. Nasseri, M., R. Hirochika, T. R. Broker, and L. Chow. 1987. A human papillomavirus type 11 transcript encoding and E1-E4 protein. Virology 159:433-439.
21. Norrild, B., C. H. Hansen, and J. A. Glahder. 2007. Identification and activity of promoters in the HPV genome, p. 1-26. In B. Norrild (ed.), Human papillomavirus gene regulation and transformation. Transworld Research Network, Trivandrum, India.
22. Ozbun, M. A., and C. Meyers. 1997. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:5161-5172.
23. Rotenberg, M. O., L. T. Chow, and T. R. Broker. 1989. Characterisation of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Virology 172:489-497.
24. Rush, M., X. Zhao, and S. Schwartz. 2005. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression. J. Virol. 79:12002-12015.
25. Schmitt, M., V. Dalstein, T. Waterboer, C. Clavel, L. Gissman, and M. Pawlita. 2010. Diagnosing cervical cancer and high-grade precursors by HPV-16 transcription patterns Cancer Res. 70:249-256.
26. Schwartz, S. 2008. HPV-16 RNA processing. Front. Biosci. 13:5880-5891.
27. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. U. S. A. 83:4680-4684.
28. Sokolowski, M., H. Furneaux, and S. Schwartz. 1999. The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3′ untranslated region correlates with its affinity for the elav-like HuR protein. J. Virol. 73:1080-1091.
29. Somberg, M., M. Rush, J. Fay, F. Ryan, H. Lambkin, G. Akusjärvi, and S. Schwartz. 2009. Adenovirus E4orf4 induces HPV-16 late L1 mRNA production. Virology 383:279-290.
30. Somberg, M., X. Zhao, M. Fröhlich, M. Evander, and S. Schwartz. 2008. PTB induces HPV-16 late gene expression by interfering with splicing inhibitory elements at the major late 5′-splice site SD3632. J. Virol. 82:3665-3678.
31. Spångberg, K., L. Wiklund, and S. Schwartz. 2000. HuR, a protein implicated in oncogene and growth factor mRNA decay, binds to the 3′ ends of hepatitis C virus RNA of both polarities. Virology 274:378-390.
32. Wiklund, L., M. Sokolowski, A. Carlsson, M. Rush, and S. Schwartz. 2002. Inhibtion of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability in the HPV-1 late 3′ untranslated region. J. Biol. Chem. 277:40462-40471.
33. Zhao, X., D. Öberg, M. Rush, J. Fay, H. Lambkin, and S. Schwartz. 2005. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFIP1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J. Virol. 79:4270-4288.
34. Zhao, X., M. Rush, A. Carlsson, and S. Schwartz. 2007. The presence of inhibitory RNA elements in the late 3′-untranslated region is a conserved property of human papillomaviruses. Virus Res. 125:135-144.
35. Zhao, X., M. Rush, and S. Schwartz. 2004. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol. 78:10888-10905.
36. Zheng, Z. M., and C. C. Baker. 2006. Papillomavirus genome structure, expression, and posttranscriptional regulation. Front. Biosci. 11:2286-2302.
37. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.